Results 21 to 30 of about 15,976 (198)

Prognostic value of myopic disk deformation in myopic choroidal neovascularization: A 6-year follow-up study [PDF]

Frontiers in Medicine, 2022
PurposeTo evaluate the clinical characteristics of myopic choroidal neovascularization (mCNV) according to peripapillary atrophy (PPA) and optic disk tilt and to explore whether those myopic disk deformations are associated with the prognosis of mCNV ...
Ye Eun Han, Yoon Jeon Kim, Hyun Seung Yang, Byung Gill Moon, Joo Yong Lee, June-Gone Kim, Young Hee Yoon   +6 more
doaj   +2 more sources

RELATIONSHIP BETWEEN MYOPIC CHOROIDAL NEOVASCULARIZATION ACTIVITY AND PERFORATING SCLERAL VESSELS IN HIGH MYOPIA. [PDF]

Retina, 2022
Ruiz-Medrano J, Almazan-Alonso E, Flores-Moreno I, Puertas M, García-Zamora M, Ruiz-Moreno JM.   +5 more
europepmc   +2 more sources

Real-World Anti-Vascular Endothelial Growth Factor Therapy Outcomes in Myopic Choroidal Neovascularization [PDF]

Clinical Ophthalmology, 2021
Devangna Bhatia, Alexander Mehta, Joanna DaCosta, Oonagh Crothers, James Stephen Talks Newcastle Eye Centre, Royal Victoria Infirmary, Newcastle upon Tyne, UKCorrespondence: Devangna BhatiaNewcastle Eye Centre, Royal Victoria Infirmary, Newcastle upon ...
Bhatia D, Mehta A, DaCosta J, Crothers O, Talks JS   +4 more
doaj   +2 more sources

Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization [PDF]

Scientific Reports, 2018
The authors performed a retrospective and comparative study to compare the efficacy of intravitreal aflibercept and bevacizumab for patients with myopic choroidal neovascularization (mCNV).
Jia-Kang Wang, Tzu-Lun Huang, Pei-Yao Chang, Yen-Ting Chen, Chin-Wei Chang, Fang-Ting Chen, Yung-Ray Hsu, Yun-Ju Chen   +7 more
doaj   +2 more sources

High‑dose aflibercept injection has striking effects on myopic choroidal neovascularization. [PDF]

Exp Ther Med, 2023
The aim of the present study was to evaluate the 1-year outcomes of a high-dose aflibercept injection [4 mg 2+ pro re nata (PRN) scheme] for individuals with myopic choroidal neovascularization (mCNV) through optical coherence tomography (OCT) follow-ups.
Zhu W, Hao Y, Yuan Z, Huang C.
europepmc   +2 more sources

The clinical effects and mechanism of action of ranibizumab in treating myopic choroidal neovascularization. [PDF]

Int Ophthalmol
Myopic choroidal neovascularization (CNV) is a common reason for visual impairment. This study investigated the clinical effects of repeated intravitreal injections of ranibizumab among patients with CNV secondary to pathologic myopia.
Gu W, Wang Z, Peng D, Gu Y.
europepmc   +2 more sources

Ten-Year Outcomes of Intravitreal Bevacizumab for Myopic Choroidal Neovascularization: Analysis of Prognostic Factors. [PDF]

Pharmaceuticals (Basel), 2021
Mallone F, Giustolisi R, Franzone F, Marenco M, Plateroti R, Nebbioso M, Lambiase A, Gharbiya M.   +7 more
europepmc   +3 more sources

Optical coherence tomography Angio-B mode for early detection of myopic choroidal neovascularization and treatment with Bevacizumab. [PDF]

Am J Ophthalmol Case Rep
Rico S, Sher I, Lavinsky F, Lavinsky D, Rotenstreich Y.   +4 more
europepmc   +2 more sources

Macular density alterations in myopic choroidal neovascularization and the effect of anti-VEGF on it. [PDF]

Int J Ophthalmol, 2021
Mao JB, Shao YR, Yu JF, Deng XY, Liu CY, Chen YQ, Zhang Y, Xu ZK, Wu SL, Shen LJ.   +9 more
europepmc   +2 more sources

Real-World Treatment Intensity and Patterns in Patients With Myopic Choroidal Neovascularization: Common Data Model in Ophthalmology. [PDF]

J Korean Med Sci, 2023
Background A paucity of data addressing real-world treatment of myopic choroidal neovascularization (mCNV) in the era of anti-vascular endothelial growth factor (VEGF) drugs led us to investigate real-world treatment intensity and treatment patterns in ...
Bui MH, Lee DY, Park SJ, Park KH.
europepmc   +2 more sources